Praxis Precision Medicines, Inc.
PRAX · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -4.73 | -0.24 | -0.95 | -0.09 |
| FCF Yield | -6.07% | -6.64% | -3.65% | -2.53% |
| EV / EBITDA | -10.50 | -8.47 | -20.71 | -16.21 |
| Quality | ||||
| ROIC | -18.78% | -16.97% | -14.31% | -14.78% |
| Gross Margin | 0.00% | 0.00% | 99.37% | 100.00% |
| Cash Conversion Ratio | 0.88 | 0.77 | 0.76 | 0.96 |
| Growth | ||||
| Revenue 3-Year CAGR | 56.90% | 74.39% | 128.25% | 2,044,960.49% |
| Free Cash Flow Growth | -3.49% | 5.66% | -104.08% | -0.81% |
| Safety | ||||
| Net Debt / EBITDA | 2.20 | 2.20 | 3.35 | 2.94 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -56,410.43 | 0.00 | -23,989.79 | 0.00 |